Primary hypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: Intervention group: After establishing communication between the researcher and the people of the intervention group in messengers selected from the previously announced priorities (So
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnosis of primary hypertension by a physician Minimum use of one anti-hypertensive medication prescribed by a physician Age between 18 to 65 years Ability to read and write (being literate) Possession of a smartphone and ability to use it and access the internet The ability to use the facilities of social messaging platforms (the person should have the minimum ability to send and receive messages in any possible form (text, voice, etc.) Have an account in at least one social messaging platform such as Whats App, Telegram, Eitaa, Soroush)
Exclusion criteria
Exclusion criteria: Participation in previous similar studies Concurrent involvement in other research or interventions Use of special or expensive medications Use of injectable anti hypertensive drugs Having sensory impairments including vision, hearing, and touch Addiction to drugs,narcotics presence of comorbidities (such as diabetes, asthma, cancer, and renal disorders)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication Adherence. Timepoint: Before intervention and 97 days after the intervention. Method of measurement: Hill-Bone Medication Adherence Scale (HB-MAS9) ,Kim et al. 2000. | — |
Secondary
| Measure | Time frame |
|---|---|
| Controlled blood pressure: In this study, blood pressure less than 140 mm Hg (systolic) and 90 mm Hg (diastolic) will be considered as controlled blood pressure. Timepoint: Before implementing the intervention at the beginning of the study (baseline) and then 97 days after the onset of interactive intervention. Method of measurement: In this study, blood pressure measurements will be taken from the participants after they’ve rested for five minutes in a seated position. A calibrated sphygmomanometer will be used on the patient’s right arm for these measurements. This process will be repeated twice, with a 10-minute interval between the measurements. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Negarandeh
Tehran University of Medical Sciences
Outcome results
None listed